Neurovascular Embolectomy Device Market (Type: Aspiration devices, Stent retrievers) - Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2025

Category : Healthcare and Pharmaceuticals | Delivery Format : PDF | Status: Published | Pages : 141

Introduction

Neurovascular embolectomy device is used during an embolectomy procedure. These devices are used for removal of emboli, obstructing the blood circulation, surgically. Usually, embolectomy is the least preferred option for treatment and other involved therapeutic options are anticoagulation and thrombolysis. Neurovascular device market has undergone a demand-shift with respect to products and techniques. Doctors want to adopt instruments and techniques that offer higher window for stroke treatment with high success rate and minimal post-surgical impact. This is supported by the fact that demand for bare platinum coils is growing at a higher pace in comparison to coated coils. This is mainly due to high costs of coated coils and their less improved clinical outcomes compared to bare platinum coils. Additionally, stroke treatment involves high healthcare expenditure that drives the focus on development of economical treatment techniques.

Market Dynamics

Neurovascular embolectomy device market is driven by increasing cases of strokes, innovation and product development, international trade, and increasing consumer awareness for strokes across the globe. Globally, the expenditure capacity of consumers has risen. Superior healthcare treatment with better devices that offer improved success rate increase the adoption of neurovascular embolectomy devices. Growing consumer knowledge for post surgery safety has increased the application of apt devices suitable for patients. Hence, rising expenditure capacity and increasing knowledge of consumers are also fuelling the demand of neurovascular embolectomy devices market. Also, elevated incidences of reinstating blood flow along with high success rates of functional independence among patients also support the market growth. Large scale random trails in year 2016-17 deep-rooted the significance of speedily clearing the occlusive clot from brain. Additionally, rising healthcare awareness is fuelling the growth of global clot neurovascular embolectomy devices market. Conversely, scarcity of skilled doctors and insufficient reimbursements in developing nations are key factors restraining the growth of the market. Furthermore, there are stringent compliances that device manufacturers & user facilities have to adhere to. These compliances must be reported as per the FDA’s user facility reporting requirement. This enables FDA to identify & analyze the risk related with neurovascular embolectomy devices.

Among neurovascular embolectomy device application fragments, stent retrievers held most astounding piece of the overall industry in 2017 as far as income and volume are concerned. Owing to the factors such as unique overlapping stent retriever-based technology, restores blood flow and retrieves clots from occluded blood vessels in the brain for patients experiencing acute ischemic stroke (AIS) due to a large vessel occlusion (LVO). In fact, the Solitaire device is indicated to reduce stroke-related disability by showing nearly 70% relative improvements in functional outcomes at 90 days in patients suffering a large vessel occlusion. North America is the largest market for neurovascular devices. As per Stroke Association, approximately 1 million Americans each year are affected by stroke which is one of the leading triggers of disability and death. Solitarily in the U.S., the financial drain of stroke is valued at around USD 30 billion annually, which includes the expenditure on health care services, prescriptions, and reduced output. The ASA has put up great effort to transform the existing healthcare systems and patients worldwide by collaborating with other countries, governments and international cerebrovascular societies. Europe is the second largest market for neurovascular embolectomy devices. However, the adoption rate of neurovascular embolectomy devices in Europe is less than that of North America. This is owing to the compliances laid down by European Union regulatory authority. Pursued by, China and India which also experiences similar stroke risk factors as western countries.

Report Coverage

Market

Global Neurovascular Embolectomy Device Market

Analysis Period

2013-2025

Base Year

2017

Forecast Data

2018 – 2025

Market Stratification

Product, Geography

Regional Scope

North America, Europe, China, Japan, Southeast Asia, India

Report Coverage

Market Trends, Drivers, Restraints, Competitive Analysis, Player Profiling, Regulation Analysis

 

The market research study on “Neurovascular Embolectomy Device Market (Product: Aspiration devices, Stent retrievers) – Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2025” offers a detailed insights on the global neurovascular embolectomy device market entailing insights on its different market segments. Market dynamics with drivers, restraints and opportunities with their impact are provided in the report. The report provides insights on global neurovascular embolectomy device market, its product, and major geographic regions. The report covers basic development policies and layouts of technology development processes. Secondly, the report covers global neurovascular embolectomy device market size and volume, and segment markets by product and geography along with the information on companies operating in the market. The neurovascular embolectomy device market analysis is provided for major regional markets including North America, Europe, China, Japan, Southeast Asia, India, followed by major countries. For each region, the market size and volume for different segments has been covered under the scope of report. The players profiled in the report include Medtronic, Boston Scientific Corporation, Teleflex Inc, DePuy Synthes, Cook Medical, Straub Medical AG, LeMaitre Vascular, Inc, Edwards Lifesciences Corporation, iVascular SLU among others.

The global Neurovascular Embolectomy Device market is segmented as below

Market Segmentation

Market By Product

  • Aspiration Systems
  • Stent Retreival Systems

Market By Geography

  • North America
  • Europe
  • China
  • Japan
  • Southeast Asia
  • India
  • Rest of World


Related Reports

Macular Degeneration Treatment Market (By Disease Indication: Dry Age-related Macular Degeneration Treatment, Wet Age-related Macular Degeneration Treatment, Others; By Drug Class: Anti-vascular endothelial growth factor, Others; By End-user: Ambulatory Surgical Centers, Hospitals, Ophthalmic Clinics) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2026

Introduction The global macular degeneration treatment Market is estimated to value US$ 11.4 Billion by 2026 and the market is projected to showcase 6.6% CAGR during the forecast period. The macular degeneration treatment market is driven by surge in healthcare spending and improved in healthcare infrastructure. Market D

Gynecological Devices Market (By Device: Surgical Devices [Endoscopy Devices, Fluid Management Systems, Endometrial Ablation Devices, Contraceptive Devices, Others], Diagnostic Imaging Systems [Ultrasound, Mammography, MRI, Others], Hand Held Instruments [Biopsy Forceps, Tenaculum, Curettes, Others], Software, Others; By End-Users: Hospitals, Clinics, Diagnostic Centres, Research Institutes, Others) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2026

Introduction The global Gynecological Devices market was valued at $9.4 billion in 2018 and is anticipated to grow at a CAGR of 7.9% during the forecast period. Gynecological devices include instruments and devices used for the treatment of diseases related to the female reproductive system. These devices include surgical devices, handheld instruments, diagnostic i

Transfusion Technology Market (By Product: Instruments [Apheresis System & Multicomponent Collection Systems, Cell Processing Systems & Cell Expansion Systems, Auto Transfusion Devices, Others], Disposables & Consumables; By End-user: Hospitals, Blood Banks, Biotechnology & Pharmaceutical Companies, Others ) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2026

Introduction The international transfusion technology market’s worth is likely to touch USD 7,138 Million by 2026 and the market is expected to project a CAGR of 5.4% during the upcoming years. Market Dynamics The worldwide transfusion technology market is described by

Lyophilized Injectable Drugs Market (By Packaging Type: Specialty Packaging, Point-Of-Care Reconstitution, Single-Use Vials, Others; By Type of Delivery: Single-step Devices, Multi-step Devices, Prefilled Diluent Syringes, Proprietary Reconstitution Devices; By Indication: Infectious Diseases, Autoimmune Diseases, Metabolic Conditions, Others; By End-user: Ambulatory Surgical Centers, Hospitals, Specialty Clinics, Others) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2026

Introduction The global lyophilized injectable drugs market is projected to worth $4,350.3 Million by 2026 and the market is projected to showcase 6.9% CAGR during the forecast period. The lyophilized injectable drugs market is expected to grow at a rapid pace owing to the increase in development of pipeline of lyophilized injectable drugs.

Cardiac Ablation Technologies Market (By Technology Type: Radiofrequency, Cryoablation, Laser, Ultrasound, Microwave, Others; By Application: Atrial fibrillation, Ventricular Tachycardia, Others) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2026

Introduction The global cardiac ablation technologies Market is project worth US$ 3,450.5 Million in 2017 and the market is projected to showcase 11.4% CAGR during the forecast period. The cardiac ablation technologies market is driven by rising incidence of atrial fibrillation and technological advancement. Market Dynam

Cart Summary